Bristol Myers (BMY)
NYSE:BMY

Bristol Myers (BMY) Income Statement

8,783 Followers

Bristol Myers Income Statement

Last quarter (Q1 2023), Bristol Myers's total revenue was $11.34B, a decrease of -2.67% from the same quarter last year. In Q1, Bristol Myers's net income was $2.27B. See Bristol Myers’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 45.85B$ 44.67B$ 46.38B$ 42.52B$ 26.14B$ 22.56B
Cost of Revenue
$ 12.56B$ 10.14B$ 9.94B$ 11.77B$ 8.08B$ 6.47B
Gross Profit
$ 33.28B$ 25.61B$ 36.45B$ 30.75B$ 18.07B$ 16.09B
Operating Expense
$ 24.49B$ 17.32B$ 29.07B$ 29.10B$ 12.46B$ 10.98B
Operating Income
$ 8.79B$ 8.29B$ 7.38B$ 1.65B$ 5.61B$ 5.11B
Net Non Operating Interest Income Expense
$ -516.00M-$ -1.33B$ -1.42B$ -656.00M$ -183.00M
Other Income Expense
$ 84.00M$ 576.00M$ 2.05B$ -7.10B$ 19.00M$ 1.04B
Pretax Income
$ 8.80B$ 7.71B$ 8.10B$ -6.87B$ 4.97B$ 5.97B
Tax Provision
$ 1.47B$ 1.37B$ 1.08B$ 2.12B$ 1.51B$ 1.02B
Earnings From Equity Interest Net Of Tax
$ -20.00M-----
Net Income Common Stockholders
$ 7.32B$ 6.33B$ 6.99B$ -9.02B$ 3.44B$ 4.92B
Basic EPS
$ 3.46$ 2.97$ 3.15$ -3.99$ 2.02$ 3.01
Diluted EPS
$ 3.43$ 2.95$ 3.12$ -3.99$ 2.01$ 3.01
Basic Average Shares
$ 8.47B-$ 2.22B$ 2.26B$ 1.71B$ 1.63B
Diluted Average Shares
$ 8.53B-$ 2.25B$ 2.26B$ 1.71B$ 1.64B
Dividend Per Share
$ 2.22-$ 2.01$ 1.84$ 1.68$ 1.61
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
$ 5.74-$ 7.51$ 6.44$ 4.69$ 3.98
Rent Expense Supplemental
------
Total Expenses
$ 37.06B$ 27.46B$ 39.01B$ 40.87B$ 20.53B$ 17.45B
Net Income From Continuing And Discontinued Operation
$ 7.32B$ 6.34B$ 6.99B$ -9.02B$ 3.44B$ 4.92B
Normalized Income
$ 5.66B-$ 7.43B$ -1.68B$ 3.48B$ 4.85B
Interest Expense
$ 906.00M-$ 1.33B$ 1.42B$ 656.00M$ 183.00M
EBIT
$ 9.31B$ 7.71B$ 9.43B$ -5.45B$ 5.63B$ 6.15B
EBITDA
$ 19.43B$ 17.99B$ 20.12B$ 4.93B$ 7.38B$ 6.79B
Currency in USD

Bristol Myers Earnings and Revenue History


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis